Genetic analysis of the role of protein kinase C signaling pathways in behaviors by direct gene transfer with HSV-1 vectors

Reviews in the Neurosciences

Volumn 10, Issue 1, 1999, Pages 1-13

  Geller, Alfred I ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Basal ganglia; Behavior; Genetic intervention; Helper virus free packaging; Herpes simplex virus type 1 vectors; Learning and memory; Nigrostriatal neurons; Protein kinase C

Indexed keywords

DOPAMINE 2 RECEPTOR; PROTEIN KINASE C; TYROSINE 3 MONOOXYGENASE; VIRUS VECTOR;

ANIMAL TISSUE; BEHAVIOR MODIFICATION; CIRCLING BEHAVIOR; GENE TRANSFER; GENETIC ANALYSIS; HERPES SIMPLEX VIRUS 1; MICROINJECTION; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE CELL;

EID: 0032821502     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro.1999.10.1.1     Document Type: Review

References (106)

1. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S. Modified hippocampal long-term potentiation in PKCγ-mutant mice. Cell 1993; 75: 1253-1262.
2. Abeliovich A, Paylor R, Chen C, Kim JJ, Wehner JM, Tonegawa S. PKCγ mutant mice exhibit mild deficits in spatial and contextual learning. Cell 1993; 75: 1263-1271.
3. Akers RF, Routtenberg A. Protein kinase C phosphorylates a 47 Mr protein (F1) directly related to synaptic plasticity. Brain Res 1985; 334: 147-151.
4. Akers RF, Lovinger DM, Colley PA, Linden DJ, Routtenberg A. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 1986; 231: 587-589.
5. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS. An ion channel locus for protein kinase C: potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 1991; 57: 1398-1404.
6. Battleman DS, Geller AI, Chao MV. HSV-1 vector mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high affinity NGF binding. J Neurosci 1993; 13: 941-951.
7. Bergold PJ, Casaccia-Bonnefil P, Xiu-Liu Z, Federoff HJ. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci USA 1993; 90: 6165-6169.
8. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993; 361: 31-39.
9. Boothman DA, Geller AI, Pardee AB. Expression of the E. coli Lac Z gene in various human normal, cancer-prone, and tumor cells using a defective HSV-1 vector. FEBS Lett 1989; 258: 159-162.
10. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ. Sensitization to morphine induced by viral-mediated gene transfer. Science 1997; 277: 812-814.
11. 2+ channels. Ann NY Acad Sci 1993; 707: 1-19.
12. Chen C, Kano M, Abelovich A, Chen L, Bao S, Kim JJ, Hashimoto K, Thompson RF, Tonegawa S. Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKCγ mutant mice. Cell 1995; 83: 1233-1242.
13. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634.
14. Coffey ET, Sihra TS, Nicholls DG. Protein kinase C and the regulation of glutamate exocytosis from cerebrocortical synaptosomes. J Biol Chem 1993; 268: 21060-21065.
15. Creese I, Snyder SH. Dopamine receptor binding enhancement accompanies lesion-induced behavior supersensitivity. Science 1977; 197: 596-598.
16. Cunningham C, Davison AJ. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 1993; 197: 116-124.
17. Davidson I, Stow ND. Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells contain a fragment of herpes simplex virus DNA. Virology 1985; 141: 77-88.
18. Davison MJ, Preston VG, McGeoch DJ. Determination of the sequence alteration in the DNA of the herpes simplex virus type 1 temperature-sensitive mutant ts K. J Gen Virol 1984; 65: 859-863.
19. DeLuca NA, McCarthy AM, Schaeffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-570.
20. Dudai Y. The Neurobiology of Memory. Oxford: Oxford University Press, 1989.
21. During MJ, Naegele J, O'Malley KL, Geller AI. Long-term behavioral recovery in a model of Parkinson's disease by intrastriatal expression of tyrosine hydroxylase. Science 1994; 266: 1399-1403.
22. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain. IV. Topography of the dopaminergic projection to the basal forebrain and neostriatum. J Comp Neurol 1978; 180: 545-580.
23. Favaron M, Manev H, Siman R, Bertolino M, Szekely AM, DeErausquin G, Guidotti A, Costa E. Down-regulation of proetin kinase C protects cerebellar granule neurons in primary culture from glutamate-induced neuronal death. Proc Natl Acad Sci USA 1990; 87: 1983-1987.
24. Federoff, HJ, Geschwind MD, Geller AI, Kessler JA. Expression of NGF in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic neurons. Proc Natl Acad Sci USA 1992; 89: 1636-1640.
25. Fink SL, Chang LK, Ho DY, Sapolsky RM. Defective herpes simplex virus vectors expressing the rat brain stress-inducible heat shock protein 72 protect cultured neurons from severe heat shock. J Neurochem 1997; 68: 961-969.
26. Fotaki ME, Pink JR, Mous J. Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Therapy 1997; 4: 901-908.
27. Fraefel C, Song S, Lim F, Lang P, Yu L, Wang Y, Wild P, Geller AI. Helper virus-free transfer of HSV-1 plasmid vectors into neural cells. J Virol 1996; 70: 7190-9197.
28. Freese A, Geller AI. Infection of striatal neurons with a defective HSV-1 vector: implications for gene therapy of Huntington's and Parkinson's diseases. Nucl Acid Res 1991; 19: 7219-7223.
29. Geller AI, Breakefield XO. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 1988; 241: 1667-1669.
30. Geller AI, During MJ, Haycock JW, Freese A, Neve RL. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a HSV-1 vector. Proc Natl Acad Sci USA 1993; 90: 7603-7607.
31. Geller AI, During MJ, Neve RL. Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci 1991; 14: 428-432.
32. Geller AI, Keyomarski K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc Natl Acad Sci USA 1990; 87: 8950-8954.
33. Geller AI, Freese A, During MJ, O'Malley KL. A HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-Dopa from cultured rat striatal cells. J Neurochem 1995; 64: 487-496.
34. Geller AI, Zhang G, Neill J, Sarkisian M, Wang Y, Liu Z, Yu L, Tandon P, Holmes G, Cook R. Altered rat visual and auditory learning after direct gene transfer of constitutively active PKC into hippocampal neurons. Soc Neurosci Abst 1998; 24: 366.1.
35. Geller AI. A system, using neural cell lines, to characterize HSV-1 vectors containing genes which effect neuronal physiology, or neuronal promoters. J Neurosci Meth 1991; 36: 91-103.
36. Geller AI, Freese A. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidase. Proc Natl Acad Sci USA 1990; 87: 1149-1153.
37. Geschwind MD, Hartnick CJ, Liu W, Amat J, Van De Water TR, Federoff HJ. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther 1996; 7: 173-182.
38. Geschwind MD, Kessler JA, Geller AI, Federoff HJ. Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector. Mol Brain Res 1994; 24: 327-335.
39. Glick SD, Weaver LM, Meibach RC. Amphetamine-induced rotation in normal cats. Brain Res 1981; 208: 227-229.
40. Goodman LJ, Valverde J, Lim F, Geswind MD, Federoff HJ, Geller AI, Hefti F. Regulated release and polarized localization of brain-derived neurotrophic factor (BDNF) in hippocampal neurons. Mol Cell Neurosci 1996; 7: 222-238.
41. Hanks SK, Quinn AM, Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 1988; 241: 42-52.
42. Hansson E. Accumulation of putative amino acid neurotransmitters, monoamines and D-Ala2-Metenkephalinamide in primary astroglial cultures from various brain areas, visualized by autoradiography. Brain Res 1983; 289: 189-196.
43. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Mol Brain Res 1996; 41: 200-2009.
44. Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective HSV-1 vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 1993; 90: 3655-3659.
45. Ho DY, Fink SL, Lawrence MS, Meier TJ, Saydam TC, Dash R, Sapolsky RM. Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J Neurosci Meth 1995; 57: 205-215.
46. Hrabetova S, Sacktor TC. Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression. J Neurosci 1996; 16: 5324-5333.
47. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-387.
48. Jerussi TP, Glick SD. Drug-induced rotation in rats without lesions: Behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function. Psychopharmacology 1976; 47: 249-260.
49. Jin BK, Belloni M, Conti B, Federoff HJ, Starr R, Son JH, Baker H, Joh TH. Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum Gene Ther 1996; 7: 2015-2024.
50. Johnson PA, Miyanohara A, Levine F, Cahill T, Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol 1992; 66: 2952-2965.
51. Johnson PA, Wang MJ, Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol 1994; 68: 6347-6362.
52. Johnson PA, Yoshida K, Gage FH, Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Res 1992; 12: 95-102.
53. Kandel ER, Schwartz JH. Molecular biology of learning: modulation of transmitter release. Science 1982; 218: 433-443.
54. Kano M, Hashimoto K, Chen C, Abelovich A, Aiba A, Kurihara H, Wantabe M, Inoue Y, Tonegawa S. Impaired synapse elimination during cerebellar development in PKCγ mutant mice. Cell 1995; 83: 1223-1231.
55. Kaplitt MG, Kwong AD, Kleopoulos SP, Mobbs CV, Rabkin SD, Pfaff DW. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer-via a defective herpes simplex viral vector. Proc Natl Acad Sci USA 1994; 91: 8979-8983.
56. Kazmarek LK, Levitan IB. Neuromodulation: The biochemical control of neuronal excitability. New York: Oxford University Press, 1987.
57. Kishimoto A, Mikawa K, Hashimoto K, Yasuda I, Tanaka S, Tominaga M, Kuroda T, Nishizuka Y. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 1989; 264:4088-4092.
58. Klawans HL, Hitri A, Carvey PM, Nausieda PA, Weiner WJ. Effect of chronic dopaminergic agonism on striatal membrane dopamine binding. Adv Neurol 1979; 24: 77-83.
59. Knopf JL, Lee MH, Sultzman LA, Kriz RW, Loomis CR, Hewick RM, Bell RM. Cloning and expression of multiple protein kinase C cDNAs. Cell 1986; 46: 491-502.
60. Kow LM, Brown HE, Pfaff DW. Activation of protein kinase C in the hypothalamic ventromedial nucleus or the midbrain central gray facilitates lordosis. Brain Res 1994; 660: 241-248.
61. Lawrence MS, Ho DY, Dash R, Sapolsky RM. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci USA 1995; 92: 7247-7251.
62. Lawrence MS, Ho DY, Sun GH, Steinberg GK, Sapolsky RM. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci 1996; 16: 486-496.
63. Lawrence MS, McLaughlin JR, Sun GH, Ho DY, McIntosh L, Kunis DM, Sapolsky RM, Steinberg GK. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cerebr Blood Flow Metab 1997; 17: 740-744.
64. Levitan IB. Modulation of ion channels by protein phosphorylation and dephosphorylation. Ann Rev Physiol 1994; 56: 193-212.
65. Lim F, Hartley D, Starr P, Lang P, Song S, Yu L, Wang Y, Geller AI. Generation of high titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. BioTechniques 1996; 20: 460-470.
66. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26, 1670-1675.
67. Lu B, Federoff HJ. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum Gene Ther 1995; 6: 419-428.
68. A receptor. J Neurochem 1993; 61: 375-377.
69. Mao J, Price DD, Mayer DJ, Hayes RL. Pain related increases in spinal cord membrane-bound protein kinase C following peripheral nerve injury. Brain Res 1992; 588: 144-149.
70. Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, McCutcheon K, Singaraja R, Kazemi-Esfarjani P, Devon R, Kim SU, Bredesen DE, Tufaro F, Hayden MR. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 1998; 18: 150-154.
71. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18-27.
72. McLauchlan J, Addison C, Craigie MC, Rixon FJ. Noninfectious L-particles supply functions which can facilitate infection by HSV-1. Virology 1992; 190: 682-688.
73. +. J Neurochem 1990; 56: 86-94.
74. Meier TJ, Ho DY, Sapolsky RM. Increased expression of calbindin D28k via herpes simplex virus amplicon vector decreases calcium ion mobilization and enhances neuronal survival after hypoglycemic challenge. J Neurochem 1997; 69: 1039-1047.
75. 3H] spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res 1984; 302: 9-18.
76. Neve RL, Howe JR, Hong S, Kalb RG. Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience 1997; 79: 435-447.
77. Nicholls DG, Sihra TS, Sanchez-Prieto J. Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem 1986; 49: 50-57.
78. Nichols RA, Haycock JW, Wang JTK, Greengard P. Phorbol ester enhancement of neurotransmitter release from rat brain synaptosomes. J Neurochem 1987; 48: 615-621.
79. Numann R, Catterall WA, Scheuer T. Functional modulation of brain sodium channels by protein kinase C phosphorylation. Science 1991; 254: 115-118.
80. Oh YJ, Moffat M, Wong S, Ullrey D, Geller AI, O'Malley KL. A herpes simplex virus-1 one vector containing the rat tyrosine hydroxylase promoter directs cell-type specific expression of beta-galactosidase in cultured rat peripheral neurons. Mol Brain Res 1996; 35: 227-236.
81. Olds JL, Anderson ML, McPhie DL, Staten LD, Alkon DL. Imaging of memory-specific changes in the distribution of protein kinase C in the hippocampus. Science 1989; 245: 866-869.
82. Olds JL, Golski S, McPhie DL, Olton D, Mishkin M, Alkon DL. Discrimination learning alters the distribution of protein kinase C in the hippocampus of rats. J Neurosci 1990; 10: 3707-3713.
83. Patterson T, Everett RD. A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J Gen Virol 1990; 71: 1775-1783.
84. Poirier LJ, Giguere M, Marchand R. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res Bull 1983; 11: 71-397.
85. 2+-dependent and -independent release of neurotransmitters from PC12 cells: A role for protein kinase C activation? J Cell Biol 1984; 99: 628-638.
86. Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, Sublette E. Persistent activation of the ζ isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci USA 1993; 90: 8342-8346.
87. Shimazaki Y, Nishiki T, Omori A, Sekiguchi M, Kamata Y, Kozaki S, Takahashi M. Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release. J Biol Chem 1996; 271: 14548-14553.
88. Smith IL, Hardwicke MA, Sandri-Goldin RM. Evidence that the HSV immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 1992; 186: 74-86.
89. Smith RL, Geller AI, Escudero KW, Wilcox CL. Long-term expression in sensory neurons in tissue culture from from herpes simplex virus type 1 (HSV-1) promoters in a HSV-1-derived vector. J Virol 1995; 69: 4593-4599.
90. Song S, Wang Y, Bak SY, Lang P, Ullrey D, Neve RL, O'Malley KL, Geller AI. A HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem 1997; 68: 1792-1803.
91. Song S, Wang Y, Bak SY, During MJ, Bryan J, Ashe O, Ullrey D, Trask L, Grant F, O'Malley KL, Reidel H, Goldstein D, Neve K, LaHoste J, Marshall J, Haycock J, Neve RL, Geller AI. Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons. J Neurosci 1998; 18: 4119-4132.
92. Spear PG, Roizman B. Herpes simplex viruses. In: Tooze J, ed. DNA Tumor Viruses. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1981; 615-746.
93. Stevens JG. Latent herpes simplex virus and the nervous system. Curr Top Microbiol Immunol 1975; 70: 31-50.
94. Stevens JG, Wagner EK, Devi-rao GB, Cook ML, Feldman LT. RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056-1059.
95. Stumpo DJ, Graff JM, Albert KA, Greengard P, Blackshear PJ. Molecular cloning, characterization, and expression of a cDNA encoding the "80 to 87 kDa" myristoylated alanine-rich C kinase substrate: A major cellular substrate for PKC. Proc Natl Acad Sci USA 1989; 86: 4012-4016.
96. Szilagyi JF, Cunningham C. Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J Gen Virol 1991; 72: 661-668.
97. Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Ann Rev Neurosci 1994; 17: 551-567.
98. + and glutamate release. J Neurochem 1989; 53: 1693-1699.
99. Tingley WG, Roche KW, Thompson AK, Huganir RL. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 1993; 364: 70-73.
100. Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatial dopamine system. Brain Res 1970; 24: 485-493.
101. Wang JK, Walaas SI, Greengard P. Protein phosphorylation in nerve terminals: comparison of calcium/calmodulin-dependent and calcium/diacylglycerol-dependent systems. J Neurosci 1988; 8: 281-288.
102. Watson K, Stevens JG, Cook ML, Subak-Sharpe JH. Latency competence of thirteen HSV-1 temperature-sensitive mutants. J Gen Virol 1980; 49: 149-159.
103. Wehner JM, Sleight S, Upchurch M. Hippocampal protein kinase C activity is reduced in poor spatial learners. Brain Res 1990; 523: 181-187.
104. Wilner KD, Butler IJ, Seifert WE, Clement-Cormier YC. Biochemical alterations of dopamine receptor responses following chronic L-DOPA therapy. Biochem Pharmacol 1980; 29: 701-706.
105. Wood MJA, Byrnes AP, Pfaff DW, Rabkin SD, Charlton HM. Inflammatory effects of gene transfer into CNS with defective HSV-1 vectors. Gene Therapy 1994; 1: 283-291.
106. Xu H, Federoff H, Maragos J, Parada LF, Kessler JA. Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Develop Biol 1994; 163: 152-161.